Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Sarkar

Showing results (311-320 of 593) with videos related to

Pageof 60
Sort By:
Plos One|September 1, 2010
Epithelial to mesenchymal transition is mechanistically linked with stem cell signatures in prostate cancer cellsDejuan Kong, Sanjeev Banerjee, Aamir Ahmad, et al.
Expert Opinion on Therapeutic Targets|April 30, 2010
PAR-4 as a possible new target for pancreatic cancer therapyAsfar S Azmi, Philip A Philip, Syed F Zafar, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1984
Receptors for human alpha and beta interferon but not for gamma interferon are specified by human chromosome 21A Raziuddin, F H Sarkar, R Dutkowski, et al.
Plos One|October 12, 2012
Activation of AMP-activated protein kinase by 3,3'-Diindolylmethane (DIM) is associated with human prostate cancer cell death in vitro and in vivoDi Chen, Sanjeev Banerjee, Qiuzhi C Cui, et al.
Oncology Reports|June 10, 2005
Combination of 5-deoxy-5-fluorouridine and tamoxifen show cell-type specific antagonistic and cooperative effects on cytotoxicity in human mammary carcinoma cellsAliccia Bollig, Qian-Qian Du, Shing-Tzu Fan, et al.
Cancer Research|March 3, 2006
Down-regulation of notch-1 inhibits invasion by inactivation of nuclear factor-kappaB, vascular endothelial growth factor, and matrix metalloproteinase-9 in pancreatic cancer cellsZhiwei Wang, Sanjeev Banerjee, Yiwei Li, et al.
The Journal of Experimental Medicine|August 1, 1975
New mutant and congenic mouse stocks expressing the murine leukemia virus-associated thymocyte surface antigen GIXE Stockert, E A Boyse, Y Obata, et al.
Current Drug Targets|July 10, 2013
Functional role of miR-34 family in human cancerRui Wang, Jia Ma, Qiong Wu, et al.
Histology and Histopathology|March 16, 2007
Histological complexities of pancreatic lesions from transgenic mouse models are consistent with biological and morphological heterogeneity of human pancreatic cancerJ D Liao, N V Adsay, F Khannani, et al.
Cancer Treatment Reviews|September 10, 2008
Exploitation of protein kinase C: a useful target for cancer therapyAshhar S Ali, Shadan Ali, Bassel F El-Rayes, et al.
Pageof 60

Showing results (311-320 of 593) with videos related to

Sort By:
Pageof 60
Plos One|September 1, 2010
Epithelial to mesenchymal transition is mechanistically linked with stem cell signatures in prostate cancer cellsDejuan Kong, Sanjeev Banerjee, Aamir Ahmad, et al.
Expert Opinion on Therapeutic Targets|April 30, 2010
PAR-4 as a possible new target for pancreatic cancer therapyAsfar S Azmi, Philip A Philip, Syed F Zafar, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1984
Receptors for human alpha and beta interferon but not for gamma interferon are specified by human chromosome 21A Raziuddin, F H Sarkar, R Dutkowski, et al.
Plos One|October 12, 2012
Activation of AMP-activated protein kinase by 3,3'-Diindolylmethane (DIM) is associated with human prostate cancer cell death in vitro and in vivoDi Chen, Sanjeev Banerjee, Qiuzhi C Cui, et al.
Oncology Reports|June 10, 2005
Combination of 5-deoxy-5-fluorouridine and tamoxifen show cell-type specific antagonistic and cooperative effects on cytotoxicity in human mammary carcinoma cellsAliccia Bollig, Qian-Qian Du, Shing-Tzu Fan, et al.
Cancer Research|March 3, 2006
Down-regulation of notch-1 inhibits invasion by inactivation of nuclear factor-kappaB, vascular endothelial growth factor, and matrix metalloproteinase-9 in pancreatic cancer cellsZhiwei Wang, Sanjeev Banerjee, Yiwei Li, et al.
The Journal of Experimental Medicine|August 1, 1975
New mutant and congenic mouse stocks expressing the murine leukemia virus-associated thymocyte surface antigen GIXE Stockert, E A Boyse, Y Obata, et al.
Current Drug Targets|July 10, 2013
Functional role of miR-34 family in human cancerRui Wang, Jia Ma, Qiong Wu, et al.
Histology and Histopathology|March 16, 2007
Histological complexities of pancreatic lesions from transgenic mouse models are consistent with biological and morphological heterogeneity of human pancreatic cancerJ D Liao, N V Adsay, F Khannani, et al.
Cancer Treatment Reviews|September 10, 2008
Exploitation of protein kinase C: a useful target for cancer therapyAshhar S Ali, Shadan Ali, Bassel F El-Rayes, et al.
Pageof 60